1. Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study. Issue 10333 (9th April 2022) Authors: Piccini, Jonathan P; Caso, Valeria; Connolly, Stuart J; Fox, Keith A A; Oldgren, Jonas; Jones, W Schuyler; Gorog, Diana A; Durdil, Václav; Viethen, Thomas; Neumann, Christoph; Mundl, Hardi; Patel, Manesh R; Auer, Johann; Hubauer, Martin; Pandzic, Sead; Preishuber, Eva; Primus-Grabscheit, Carina; ... Journal: Lancet Issue: Volume 399:Issue 10333(2022) Page Start: 1383 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The IC‐D score for predicting prophylactic cardioverter‐defibrillator implantation following acute myocardial infarction. Issue 6 (24th April 2021) Authors: Clementy, Nicolas; Bensaid, Reda; Bouteau, Jérémie; Fedida, Joël; Kiavue, Yoann; Socie, Pierre; Ackermann, Romain; Goralski, Marc; Fauchier, Laurent; Bernard, Anne; Angoulvant, Denis; Babuty, Dominique Journal: Pacing and clinical electrophysiology Issue: Volume 44:Issue 6(2021) Page Start: 973 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗